ClinicalTrials.gg
CompletedNCT07411326Updated Feb 13, 2026

Does Intraoperative Application of Steroids Affect Early Outcomes in Patients Undergoing Endoscopic Lumbar Discectomy?

An interventional study of Intervention Group and Control group (Normal Saline) (C) in Lumbar Radiculopathy and Lumbar Herniated Disk, sponsored by Centro Hospitalar De São João, E.P.E.. Completed at 1 site in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Centro Hospitalar De São João, E.P.E. · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Sep 2022, registered Apr 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Prospective randomised trial assessing whether intraoperative application of steroids leads to better clinical outcomes in patients submitted to lumbar discectomy

Read the detailed description

Prospective randomised trial assessing whether intraoperative application of steroids leads to better clinical outcomes in patients submitted to lumbar discectomy A control group has hernia removal without preoperative application of dexamethasone whilst 2 mL of dexamethasone is applied to the intervention group after hernia removal The investigators evaluated outcomes through back and leg NRS 48h, 2 weeks, 1 month and 3 months after surgery and ODI at 1 and 3 months post op

02

Conditions studied

  • Lumbar Radiculopathy
  • Lumbar Herniated Disk

Keywords

  • steroids
  • lumbar radiculopathy
  • back and leg pain
  • ODI
  • endoscopic surgery
03

In context

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

This study's enrollment of 90 is above the median of 60 across 375 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Centro Hospitalar De São João, E.P.E. is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adult patients (≥18 years) Undergoing single-level full-endoscopic lumbar discectomy Symptomatic lumbar disc herniation Ability to provide written

Exclusion criteria

Exclusion Criteria:

Previous lumbar surgery at the same level Foraminal or extraforaminal disc herniations Multilevel surgery Intraoperative conversion to microdiscectomy Dural tear precluding epidural application

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Active comparator
    control group

    Patients undergoing full-endoscopic lumbar discectomy receiving epidural saline.

    Other: Control group (Normal Saline) (C)

  • Experimental
    Dexamethasone group

    Patients undergoing full-endoscopic lumbar discectomy receiving epidural dexamethasone 8 mg.

    Drug: Intervention Group

Interventions

  • DrugIntervention Group

    patients given intraoperative dexamethasone after hernia removal

  • OtherControl group (Normal Saline) (C)

    patients given 2mL saline

06

What researchers measure

Primary outcomes

  1. NRS back and NRS leg

    back and leg pain measured by a numerical rating scale. the NRS is a 0 to 10 scale in which 10 means the highest pain score

    Time frame: patients will be evaluated over a 3 month period postoperatively, first at 48 hours post surgery, then 2 weeks and 1 month after surgery.

Secondary outcomes

  1. ODI

    Oswestry disability index. he ODI is a 0 to 100 scale in which 100 represents the highest level of disability and 0 the lowest level of disability.

    Time frame: patients will be evaluated over a 3 month period postoperatively, first at 1 month and then 3 months.

07

Study locations

1 site
  • Centro Hospitalar Universitario São João
    Porto, Porto District 4445, Portugal
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2022 to primary completion in Jan 2025, 28 months.

Of 205 non-industry interventional studies with no phase under Radiculopathy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's 28 months is above that.

Counting every sponsor, half of 217 studies reached it within 12 months; a quarter within 5 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2025
First posted
Feb 13, 2026
StartActual
Sep 10, 2022
Primary completionActual
Jan 31, 2025
CompletionActual
Jan 31, 2025
Last update
Feb 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07411326
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Responsible party
Pedro Daniel Valente Aguiar (Principal Investigator, Centro Hospitalar De São João, E.P.E.) — Principal investigator
First posted
Feb 13, 2026
Start date
Sep 10, 2022
Primary completion
Jan 31, 2025
Completion
Jan 31, 2025
Last update
Feb 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion